Terms: = Kidney tumors AND PRCC, Q92733, TPRC, RCCP1, MGC4723, MGC17178, ENSG00000143294, 5546 AND Staging
17 results:
1. Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registry.
Saitta C; Afari JA; Walia A; Patil D; Tanaka H; Hakimi K; Wang L; Meagher MF; Liu F; Nguyen MV; Puri D; Cerrato C; Saidian A; Kobayashi M; Fukuda S; Fujii Y; Master V; Derweesh IH
Urol Oncol; 2024 Apr; 42(4):119.e1-119.e16. PubMed ID: 38341362
[TBL] [Abstract] [Full Text] [Related]
2. Potential role of
Aggarwal P; Singh H; Das CK; Mavuduru RS; Kakkar N; Lal A; Gorsi U; Kumar R; Mittal BR
Eur J Radiol; 2024 Jan; 170():111218. PubMed ID: 38007857
[TBL] [Abstract] [Full Text] [Related]
3. Comparison and validation of different risk models for papillary renal cell carcinoma.
Lin H; Sun Q; Li Z; Zheng J; Zhang X; Xiong Y; Chen H; Hou Y; Xi W; Lin J
Urol Oncol; 2023 Aug; 41(8):358.e1-358.e7. PubMed ID: 37394414
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in papillary renal cell carcinoma patients after receiving curative surgery based on a retrospective cohort.
Zhang Z; Yu Y; Zheng J; Zhang M; Niu H
BMC Urol; 2021 Mar; 21(1):43. PubMed ID: 33752642
[TBL] [Abstract] [Full Text] [Related]
5. Development of an Autophagy Score Signature for Predicting Overall Survival in Papillary Renal Cell Carcinoma.
Gu X; Chen X; Zhu L; Song W; Wang A; Chu J; Wang T; Jiang P; Ge Y
Dis Markers; 2020; 2020():8867019. PubMed ID: 33273989
[TBL] [Abstract] [Full Text] [Related]
6. Renal neoplasia with papillary architecture involving the pelvicalyceal system.
Gupta S; Cheville JC; Galeano BK; Sukov WR; Herrera-Hernandez L; Reed KA; Lohse CM; Thompson RH; Boorjian SA; Leibovich BC; Jimenez RE
Hum Pathol; 2021 Jan; 107():46-57. PubMed ID: 33166576
[TBL] [Abstract] [Full Text] [Related]
7. The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort.
Klatte T; Gallagher KM; Afferi L; Volpe A; Kroeger N; Ribback S; McNeill A; Riddick ACP; Armitage JN; 'Aho TF; Eisen T; Fife K; Bex A; Pantuck AJ; Stewart GD
BMC Med; 2019 Oct; 17(1):182. PubMed ID: 31578141
[TBL] [Abstract] [Full Text] [Related]
8. In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma.
Yang M; Hlady RA; Zhou D; Ho TH; Robertson KD
Cancer Med; 2019 Sep; 8(12):5760-5768. PubMed ID: 31361072
[TBL] [Abstract] [Full Text] [Related]
9. Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients.
Errarte P; Beitia M; Perez I; Manterola L; Lawrie CH; Solano-Iturri JD; Calvete-Candenas J; Unda M; López JI; Larrinaga G
PLoS One; 2017; 12(8):e0181711. PubMed ID: 28809959
[TBL] [Abstract] [Full Text] [Related]
10. Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.
Fabrizio FP; Costantini M; Copetti M; la Torre A; Sparaneo A; Fontana A; Poeta L; Gallucci M; Sentinelli S; Graziano P; Parente P; Pompeo V; De Salvo L; Simone G; Papalia R; Picardo F; Balsamo T; Flammia GP; Trombetta D; Pantalone A; Kok K; Paranita F; Muscarella LA; Fazio VM
Oncotarget; 2017 Feb; 8(7):11187-11198. PubMed ID: 28061437
[TBL] [Abstract] [Full Text] [Related]
11. Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade.
Mytsyk Y; Dutka I; Borys Y; Komnatska I; Shatynska-Mytsyk I; Farooqi AA; Gazdikova K; Caprnda M; Rodrigo L; Kruzliak P
Int Urol Nephrol; 2017 Feb; 49(2):215-224. PubMed ID: 27853915
[TBL] [Abstract] [Full Text] [Related]
12. Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2.
Geller JI; Ehrlich PF; Cost NG; Khanna G; Mullen EA; Gratias EJ; Naranjo A; Dome JS; Perlman EJ
Cancer; 2015 Jul; 121(14):2457-64. PubMed ID: 25845370
[TBL] [Abstract] [Full Text] [Related]
13. Papillary renal cell carcinoma revisited: a comprehensive histomorphologic study with outcome correlations.
Warrick JI; Tsodikov A; Kunju LP; Chinnaiyan AM; Palapattu GS; Morgan TM; Alva A; Tomlins S; Wu A; Montgomery JS; Hafez KS; Wolf JS; Weizer AZ; Mehra R
Hum Pathol; 2014 Jun; 45(6):1139-46. PubMed ID: 24767860
[TBL] [Abstract] [Full Text] [Related]
14. Chromosome 7 aneuploidy in clear cell and papillary renal cell carcinoma: detection using silver in situ hybridization technique.
Pailoor J; Rajandram R; Yap NY; Ng KL; Wang Z; Iyengar KR
Indian J Pathol Microbiol; 2013; 56(2):98-102. PubMed ID: 24056643
[TBL] [Abstract] [Full Text] [Related]
15. Expression of parafibromin in major renal cell tumors.
Cui C; Lal P; Master S; Ma Y; Baradet T; Bing Z
Eur J Histochem; 2012 Oct; 56(4):e39. PubMed ID: 23361235
[TBL] [Abstract] [Full Text] [Related]
16. Chromophobe renal cell carcinoma in Iceland: an epidemiological and clinicopathological study.
Ingimarsson JP; Hardarson S; Petursdottir V; Jonsson E; Einarsson GV; Gudbjartsson T
Scand J Urol Nephrol; 2011 Nov; 45(5):306-11. PubMed ID: 21619417
[TBL] [Abstract] [Full Text] [Related]
17. Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
Jin JS; Hsieh DS; Lin YF; Wang JY; Sheu LF; Lee WH
Int J Urol; 2006 May; 13(5):573-80. PubMed ID: 16771728
[TBL] [Abstract] [Full Text] [Related]
